Skip the clinic. Our DHA-certified nurses come to your home, hotel, or residence to administer your doctor-prescribed Mounjaro (tirzepatide) injection safely and precisely — correct dose, correct pen technique, dose escalation management, side effect monitoring, and ongoing weekly injection support. Available 24/7 across Dubai.
Mounjaro injection at home in Dubai is a professional healthcare service where a DHA-certified nurse visits your home to administer your doctor-prescribed tirzepatide dose correctly — at the right pen setting, in the right injection site, using proper subcutaneous technique — and monitors your response after every session. All Mounjaro home injection sessions comply fully with Dubai Health Authority (DHA) regulations and require a valid physician’s prescription.
Whether you are starting Mounjaro for the first time at the 2.5 mg starter dose, progressing through dose escalation towards your maintenance level, or simply prefer a qualified Mounjaro nurse in Dubai to administer each weekly injection rather than self-injecting, The Nurse Company brings clinical-grade tirzepatide administration to your door — with arrival in 30 minutes and same-day availability across Dubai.
Mounjaro (tirzepatide) is a once-weekly prescription injectable medication developed by Eli Lilly and first approved by the FDA in 2022 for blood sugar management in adults with type 2 diabetes mellitus. It is administered as a subcutaneous injection once weekly into the abdomen, outer thigh, or upper arm using a pre-filled Mounjaro KwikPen. In Dubai, Mounjaro is regulated by the Dubai Health Authority as a prescription-only medication — all home administration must be supervised by a DHA-certified healthcare professional against a valid physician’s prescription.
What makes Mounjaro clinically distinct from other GLP-1 medications is its dual-hormone mechanism. While semaglutide (Ozempic, Wegovy) targets only the GLP-1 receptor, tirzepatide acts simultaneously on both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors — two separate metabolic pathways that together regulate appetite, digestion, insulin release, and blood sugar control more powerfully than either receptor alone. This dual-action mechanism is why clinical trials of tirzepatide showed average weight reductions of 15–22.5% over 12–18 months, results that significantly outperform single-receptor GLP-1 medications across comparable study populations.
Tirzepatide works through four simultaneous effects: it stimulates insulin release from the pancreas when blood glucose is elevated; it suppresses glucagon secretion to prevent sugar spikes; it slows gastric emptying so food is digested more gradually, extending satiety; and it sends fullness signals to the brain to reduce appetite and calorie intake. According to the FDA prescribing information approved in 2022, Mounjaro is started at 2.5 mg once weekly, with dose increases in 2.5 mg increments every four weeks up to a maximum of 15 mg weekly.
In Dubai, Mounjaro is primarily prescribed for type 2 diabetes blood sugar management. Under physician supervision, it is also widely used as part of medically structured weight management programmes given its clinically established weight loss effects.
| Medication | Active Ingredient | Mechanism | Max Dose | Avg. Weight Loss | Frequency |
|---|---|---|---|---|---|
| Mounjaro | Tirzepatide | Dual GLP-1 + GIP | 15 mg | 15–22.5% | Once weekly |
| Ozempic | Semaglutide | GLP-1 only | 2 mg | 5–15% | Once weekly |
| Wegovy | Semaglutide | GLP-1 only | 2.4 mg | 12–17% | Once weekly |
| Trulicity | Dulaglutide | GLP-1 only | 4.5 mg | 3–5% | Once weekly |
| Rybelsus | Semaglutide oral | GLP-1 only | 14 mg | 3–5% | Once daily |
Having your Mounjaro (tirzepatide) injection administered at home by a DHA-certified nurse from The Nurse Company provides significant clinical, safety, and lifestyle advantages:
Mounjaro's dual GLP-1 and GIP mechanism produces significantly greater weight loss than single-receptor GLP-1 medications. Phase 3 SURMOUNT clinical trials demonstrated average weight reductions of 15–22.5% over 72 weeks at the 5–15 mg dose range — with some participants losing up to 30% of their body weight. Consistent, professionally managed weekly injections at home ensure not a single dose is missed, directly protecting these outcomes.
Mounjaro requires careful dose titration — starting at 2.5 mg for the first four weeks, then increasing by 2.5 mg increments every four weeks up to the prescribed maintenance dose (5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg). Each escalation step increases the temporary risk of GI side effects. Our nurses confirm the exact dose at every visit, apply the correct KwikPen setting, and monitor your response through every dose level change — preventing the common error of escalating too early.
Incorrect injection depth, wrong angle, failure to pinch the skin correctly, or repeated use of the same injection site causes lipohypertrophy — fatty tissue buildup that reduces medication absorption and compromises results. Our DHA-certified nurses apply the correct 90-degree injection angle, appropriate skin fold technique, and systematic site rotation across abdomen, thigh, and upper arm at every weekly visit.
The most common Mounjaro side effects — nausea, diarrhoea, vomiting, constipation, and reduced appetite — are most pronounced during the first weeks of therapy and at each dose escalation. Our nurses monitor your response after each injection, provide evidence-based management guidance, and flag significant side effects to your prescribing physician so dosing can be adjusted if needed.
Many Dubai patients prescribed Mounjaro experience anxiety about the weekly injection — particularly those unfamiliar with the KwikPen mechanism, needle-phobic patients, or those concerned about making a technical error. Having a trained, experienced nurse administer each dose removes this barrier entirely, improving treatment confidence and adherence.
The Nurse Company provides a full range of Mounjaro administration and GLP-1 injection support services for patients across Dubai. All sessions are performed by DHA-certified nurses against a valid physician’s prescription.
For patients beginning Mounjaro therapy, our nurse visits your home for the very first 2.5 mg starter dose — preparing the KwikPen correctly, selecting and cleaning the injection site, administering the injection with correct subcutaneous technique, and monitoring your response for at least 30 minutes post-injection. We also walk you through the complete self-injection process — from pen unlocking and needle attachment to injection site selection and safe disposal — so you are fully confident to self-administer in future if you choose.
Our most popular tirzepatide service. Looking for a Mounjaro nurse in Dubai who comes to you? A DHA-certified nurse visits your home once every week — on your prescribed injection day — to administer your tirzepatide dose at the correct KwikPen setting, correct injection site, and correct technique. Weekly nurse visits are fully schedulable and available 24/7 across Dubai. This service integrates with our broader nurse at home care plans for patients with ongoing health management needs.
Every four weeks, your physician escalates your Mounjaro dose by 2.5 mg — from 2.5 mg to 5 mg, then 7.5 mg, 10 mg, 12.5 mg, and up to 15 mg maximum. Each new dose level carries a temporarily elevated risk of GI side effects as your body adjusts. Our nurses provide dedicated escalation-day visits with extended post-injection monitoring (30–60 minutes), confirming the new pen setting is correct, observing your first dose at the new level, and advising on side effect management specific to the higher dose.
Patients experiencing significant nausea, vomiting, diarrhoea, or GI discomfort during Mounjaro therapy can book a dedicated nurse support visit. Our nurse assesses your symptoms, provides clinical guidance on managing common tirzepatide side effects, and can administer supportive care such as IV antiemetics or hydration fluids if separately prescribed — directly supported by our IV injection at home service for rehydration.
For patients prescribed Mounjaro as part of a type 2 diabetes treatment plan alongside diet and exercise, our nurses provide complete weekly injection administration and blood glucose monitoring guidance. Patients on combined diabetes protocols — including insulin alongside Mounjaro — receive correctly managed, site-separated dual injections at each visit. This service is fully supported within our general nursing care at home and critical and chronic care programmes.
For patients on a physician-supervised Mounjaro weight management programme, our nurses deliver consistent weekly weight loss injection administration in Dubai — ensuring the correct dose, precise technique, and proper dose escalation that underpins the 15–22.5% average weight reduction demonstrated in SURMOUNT clinical trials. Our nurse scheduling ensures strict weekly compliance — a direct determinant of treatment outcome.
Some patients in Dubai transition from Ozempic (semaglutide) to Mounjaro (tirzepatide) under physician direction — typically when greater weight loss or improved glycaemic control is needed. Our nurses manage the transition correctly, confirming the switch protocol prescribed by your physician and applying appropriate dose and technique adjustments. For full semaglutide injection support, see our Ozempic injection at home page.
Patients on combined insulin and Mounjaro therapy receive both injections correctly managed at each nurse visit — with site separation confirmed and no mixing in the same syringe. This is a core element of our intramuscular injection at home and diabetes nursing care services.
For patients with an existing peripheral IV cannula, midline, or PICC (Peripherally Inserted Central Catheter) line requiring ongoing intravenous access, our nurses provide regular home visits for line flushing, sterile dressing changes, site inspection, and patency checks. PICC lines are commonly used for patients on extended antibiotic courses or chemotherapy — our nurses manage the full care protocol at home, coordinating with your hospital team where required. This is fully supported within our nurse at home service.
Managing Mounjaro therapy correctly requires more than a weekly pen press. The Nurse Company delivers the DHA-compliant clinical expertise, consistent care, and dose management precision that makes home-based tirzepatide treatment both safe and maximally effective.
All procedures are performed by trained professionals, certified by DHA, with extensive clinical experience.
From using disposable equipment to following hospital-grade sterilization practices, we follow international safety standards to prevent infection risks.
Each patient receives customized care based on their physical and medical needs and the doctor’s guidance.
We are available round the clock. For urgent situations, we reach your location within 30 minutes. You can also schedule appointments at your ease as well.
Our Mounjaro injection at home service supports a wide range of patients across Dubai who benefit from professional, nurse-administered tirzepatide treatment in the convenience and privacy of their own home.
Patients prescribed Mounjaro by a DHA-licensed physician for blood sugar control and HbA1c reduction receive consistent weekly injection management at home — alongside their existing regimen of diet, exercise, and diabetes medication. Our critical and chronic care service supports patients with complex, ongoing diabetes protocols.
Dubai residents seeking a weight loss injection in Dubai and prescribed Mounjaro under medical supervision receive weekly nurse-administered tirzepatide injections with full dose escalation management — supporting the clinically demonstrated 15–22.5% weight reduction over 12–18 months.
Patients prescribed Mounjaro for the first time who are anxious about self-injection — unfamiliar with the KwikPen mechanism, needle-phobic, or uncertain about technique — benefit enormously from a nurse-administered first injection and complete pen training at home.
Those experiencing significant nausea, GI discomfort, or injection site reactions during Mounjaro therapy benefit from having a nurse present at each injection for immediate side effect assessment, clinical guidance, and physician escalation when dose adjustment is needed.
Dubai professionals and travellers whose weekly schedule makes clinic visits impractical book a Mounjaro nurse in Dubai to come to their home, hotel, or office at a time that fits their day — without disrupting work or travel routines.
Senior patients with type 2 diabetes prescribed Mounjaro who find weekly clinic visits physically challenging receive complete injection care at home. Our elderly care at home service includes full medication injection support alongside broader nursing care.
Our complete and personalised home-care services make life easier, healthier, and safer for you and your loved ones. From newborn support to elderly assistance and medical care, our services cover all stages of life with compassion and clinical expertis
The Nurse Company reaches you promptly, no matter where you are in Dubai. Whether you need your weekly Mounjaro dose in Downtown Dubai, a first tirzepatide injection in Dubai Marina, or a dose escalation visit in Arabian Ranches, we ensure a fast response and expert care across all communities.
Our service coverage is not limited to homes — we also administer Ozempic injections in hotel rooms, serviced apartments, and offices across Dubai. For a full overview of our coverage, visit our home care Dubai page.
Booking a Mounjaro injection at home service with The Nurse Company is simple and hassle-free. The process is structured for weekly consistency, clinical safety, and maximum patient comfort.
Contact The Nurse Company via WhatsApp or phone. Share your prescription details, preferred time, and location. Appointments are confirmed within minutes — same-day availability in most Dubai areas.
A DHA-certified nurse arrives at your home, hotel, or office within 30 minutes. They verify your prescription, check medication sterility and dosage, review your allergy history, and select the correct injection site — deltoid, thigh, or gluteal — based on your medication and condition.
The nurse administers the IM injection using strict aseptic technique, then remains with you for 10–15 minutes to monitor for any reactions. All sharps are safely disposed of in compliance with DHA standards, and you receive a full record of the injection. For multi-day courses, your next visit is scheduled before the nurse leaves.
Call our helpline, send a WhatsApp message or request a callback by filling out the online form.
Once you contact our team, we schedule a certified nurse based on your preferred time and location.
Our professional arrives fully equipped, verifies the treatment plan issued by a certified doctor, and prepares the injection using sterile techniques with the right dose.
The nurse gets rid of medical waste immediately as per guidelines and monitors for any possible reactions.
The Nurse Company makes tirzepatide therapy simple, safe, and consistent with professional Mounjaro injection at home service in Dubai — starting from AED 149. For related GLP-1 injection services, explore our Ozempic injection at home page and our full injection at home options
Mounjaro (tirzepatide) is a once-weekly prescription subcutaneous injection by Eli Lilly, FDA-approved in 2022 for blood sugar management in adults with type 2 diabetes. It works via a dual GLP-1 and GIP receptor mechanism — the only injectable in its class to target both pathways simultaneously. In Dubai, it is prescribed by DHA-licensed physicians for type 2 diabetes and, under medical supervision, for structured weight management.
Mounjaro (tirzepatide) targets both GLP-1 and GIP receptors — a dual mechanism. Ozempic (semaglutide) targets GLP-1 only. Clinical trials show Mounjaro produces average weight loss of 15–22.5% compared to 5–15% for semaglutide, making tirzepatide the more potent option for weight management. Both require a valid prescription in Dubai. Our Ozempic injection at home service is also available if your physician prescribes semaglutide.
According to FDA prescribing guidelines, Ozempic is initiated at 0.25 mg once weekly for four weeks — a starter dose to build tolerance, not for blood sugar control. After four weeks, the dose increases to 0.5 mg weekly. If additional glycaemic control is needed after at least four weeks at 0.5 mg, the dose may increase to 1 mg, and then to the maximum of 2 mg weekly. Your physician determines your personal escalation schedule.
Mounjaro is injected subcutaneously — just under the skin — into the abdomen, outer thigh, or upper arm. Per FDA prescribing instructions, a different site should be used each week within the same body region to prevent lipohypertrophy. Our nurses manage correct site rotation at every visit.
The most common side effects of Mounjaro are gastrointestinal: nausea, diarrhoea, vomiting, constipation, and abdominal pain. These are most pronounced during the first weeks of treatment and at each dose escalation, and typically reduce as the body adjusts. Mounjaro is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Always consult your physician if side effects are severe or persistent.
Yes. Mounjaro is a prescription-only medication in the UAE, as mandated by the Dubai Health Authority. All home administrations require a valid DHA-licensed physician’s prescription specifying the medication, current dose, and injection schedule. The Nurse Company does not administer Mounjaro without a confirmed, valid prescription.
Yes. The Nurse Company provides recurring weekly nurse visits for Mounjaro injection administration across all major Dubai communities. Your nurse is scheduled consistently for the same day each week — ensuring correct dose, correct technique, and full post-injection monitoring throughout your complete treatment course.
